Boyd Consultants, an established research and drug development consultancy with offices in Cheshire and Cambridgeshire, has appointed experienced business development specialist, Lucy Robertshaw, to support the firm’s growth plans.
Lucy has many years experience working with AstraZeneca where she was part of their Global Redeployment Project, which looked at efficiency improvements, associated with focused resource utilisation.
She started her career within the medical sector after studying Business Management and Administration in Manchester.
After leaving AstraZeneca she worked as Business Development Director for Arena Instrumentation in Scandinavia where she was responsible for developing the market in both Denmark and Sweden.
Commenting on her new appointment with Boyd Consultants, Lucy said, “I am excited at the prospect of developing an already successful and established business as it enters its next phase of growth. My focus is to build on the existing successes and develop a clear strategy and vision. This new role will enable me to bring my expertise to the company whilst broadening my knowledge of drug development and strengthening my working relationships within the sector.”
Professor Alan Boyd, founder of Boyd Consultants, added, “The addition of Lucy to our team will be invaluable. We have ambitious growth plans for the coming years and recognise the need to involve dedicated professionals with the skills needed to achieve this growth. At the heart of everything we do is the passion for putting the patient first and providing advice and support to development programmes to help deliver safe and effective products for the patient. Lucy’s knowledge of the sector and understanding of our business and client needs will enable us focus on our clear strategy to have a positive impact on more development programmes.”
Boyd Consultants will be exhibiting at BioWales 2014 Conference and Exhibition in Cardiff on the 6th and 7th March.